14580
Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate
≥97.0% (TLC), for peptide synthesis
Manufacturer: Sigma Aldrich
CAS Number: 941689-36-7
Synonym(S): (S)-N-(5-Amino-1-carboxypentyl)iminodiacetic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | 14580-1-G | In Stock | ₹ 13,325.58 |
| 5 G | 14580-5-G | In Stock | ₹ 30,743.00 |
14580 - 1 G
In Stock
Quantity
1
Base Price: ₹ 13,325.58
GST (18%): ₹ 2,398.604
Total Price: ₹ 15,724.184
product name
Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate, ≥97.0% (TLC)
Quality Level
100
Assay
≥97.0% (TLC)
form
powder
reaction suitability
reaction type: solution phase peptide synthesis
application(s)
peptide synthesis
SMILES string
O.NCCCC[C@H](N(CC(O)=O)CC(O)=O)C(O)=O
InChI
1S/C10H18N2O6.H2O/c11-4-2-1-3-7(10(17)18)12(5-8(13)14)6-9(15)16;/h7H,1-6,11H2,(H,13,14)(H,15,16)(H,17,18);1H2/t7-;/m0./s1
InChI key
WTVPNZLAZFGAFK-FJXQXJEOSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Sigma Aldrich Fine Chemicals Biosciences Nalpha,Nalpha-Bis(carboxymethyl)-L-lysine hydrate >=97.0% (TLC) | 941689-36-7 | MFCD24387945 | 5G | Sigma Aldrich Fine Chemicals Biosciences | ₹ 77,436.93 | |
| | Sigma Aldrich Fine Chemicals Biosciences Nalpha,Nalpha-Bis(carboxymethyl)-L-lysine hydrate >=97.0% (TLC) | 941689-36-7 | MFCD24387945 | 1G | Sigma Aldrich Fine Chemicals Biosciences | ₹ 28,404.21 | |
 | Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate | ChemScene | ₹ 5,219.16 - ₹ 22,587.84 | |
 | 941689-36-7 | N2,N2-bis(carboxymethyl)-L-Lysine hydrate | A2B Chem | ₹ 14,288.52 - ₹ 40,042.08 |
Related Products
Description
- General description: Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate is a synthetic amino acid used in solution phase peptide synthesis.[1]
- Application: <ul><li><strong>N and alpha;N and alpha;-Bis(carboxymethyl)-lysine hydrate in Biosensor Development:</strong> Zhang et al. explored the use of functionalized graphene oxide for the fabrication of biosensors aimed at detecting paraoxon, a nerve agent, where N and alpha;N and alpha;-Bis(carboxymethyl)-lysine hydrate is used as a part of the step-by-step process to anchor onto the GO-based materials (Zhang et al., 2014).</li><li><strong>Protein Purification Enhancements:</strong>N,N-Bis(carboxymethyl)-l-lysine hydrate (ANTA) is used in the synthesis of superparamagnetic Fe3O4/Au nanoparticles as a conjugating agent. It facilitates the attachment of Co2+ ions to the surface-modified Fe3O4/Au nanoparticles, resulting in the formation of Fe3O4/Aun and ndash;ANTA and ndash;Co2+ nanoparticles (Zhang et al., 2013).</li></ul>
- Analysis Note: may contain up ~2 mol water and ~10% inorganic salts
- Other Notes: Tricarboxylic acid used for preparing chelating resins employed for the chromatography of proteins[1]
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Compare Similar Items
Show Difference
product name: Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate, ≥97.0% (TLC)
Quality Level: 100
Assay: ≥97.0% (TLC)
form: powder
reaction suitability: reaction type: solution phase peptide synthesis
application(s): peptide synthesis
SMILES string: O.NCCCC[C@H](N(CC(O)=O)CC(O)=O)C(O)=O
InChI: 1S/C10H18N2O6.H2O/c11-4-2-1-3-7(10(17)18)12(5-8(13)14)6-9(15)16;/h7H,1-6,11H2,(H,13,14)(H,15,16)(H,17,18);1H2/t7-;/m0./s1
InChI key: WTVPNZLAZFGAFK-FJXQXJEOSA-N
product name:
Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate, ≥97.0% (TLC)
Quality Level:
100
Assay:
≥97.0% (TLC)
form:
powder
reaction suitability:
reaction type: solution phase peptide synthesis
application(s):
peptide synthesis
SMILES string:
O.NCCCC[C@H](N(CC(O)=O)CC(O)=O)C(O)=O
InChI:
1S/C10H18N2O6.H2O/c11-4-2-1-3-7(10(17)18)12(5-8(13)14)6-9(15)16;/h7H,1-6,11H2,(H,13,14)(H,15,16)(H,17,18);1H2/t7-;/m0./s1
InChI key:
WTVPNZLAZFGAFK-FJXQXJEOSA-N
product name: __
Quality Level: __
Assay: __
form: __
reaction suitability: __
application(s): pharmaceutical (small molecule)
SMILES string: __
InChI: 1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22?,23+;/m1./s1
InChI key: OIXVKQDWLFHVGR-GQTDVWSESA-N
product name:
__
Quality Level:
__
Assay:
__
form:
__
reaction suitability:
__
application(s):
pharmaceutical (small molecule)
SMILES string:
__
InChI:
1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22?,23+;/m1./s1
InChI key:
OIXVKQDWLFHVGR-GQTDVWSESA-N
product name: __
Quality Level: __
Assay: __
form: __
reaction suitability: __
application(s): pharmaceutical
SMILES string: __
InChI: 1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1
InChI key: OIXVKQDWLFHVGR-WQDIDPJDSA-N
product name:
__
Quality Level:
__
Assay:
__
form:
__
reaction suitability:
__
application(s):
pharmaceutical
SMILES string:
__
InChI:
1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1
InChI key:
OIXVKQDWLFHVGR-WQDIDPJDSA-N
product name: __
Quality Level: __
Assay: __
form: __
reaction suitability: __
application(s): __
SMILES string: __
InChI: __
InChI key: __
product name:
__
Quality Level:
__
Assay:
__
form:
__
reaction suitability:
__
application(s):
__
SMILES string:
__
InChI:
__
InChI key:
__